Repurposing Canagliflozin to target brain aging

Aging (Albany NY). 2023 Mar 24;15(7):2367-2368. doi: 10.18632/aging.204624. Epub 2023 Mar 24.

Authors

Hashan Jayarathne¹, Wanqing Liu², Marianna Sadagurski¹

Affiliations

¹ Department of Biological Sciences, IBio (Integrative Biosciences Center), Wayne State University, Detroit, MI 48202, USA.
² Department of Pharmaceutical Science, IBio (Integrative Biosciences Center), Wayne State University, Detroit, MI 48202, USA.

No abstract available

Keywords: Canagliflozin; aging; brain; metabolism; sex.

Publication types

Editorial

MeSH terms

Aging
Brain
Canagliflozin / pharmacology
Canagliflozin / therapeutic use
Diabetes Mellitus, Type 2*
Humans
Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors*

Substances

Canagliflozin
Sodium-Glucose Transporter 2 Inhibitors
Hypoglycemic Agents

Grants and funding

P30 DK020572/DK/NIDDK NIH HHS/United States